Keystone Symposia

This meeting took place in 2020


Here are the related meetings in 2021:
Next Generation HIV Vaccines & Therapies (B4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

MEETING CANCELLED: HIV Vaccines (X5)


Organizer(s) Persephone Borrow, Georgia D. Tomaras and Rogier W. Sanders
March 22—26, 2020
Keystone Resort • Keystone, CO USA
Discounted Abstract Deadline: Nov 20, 2019
Abstract Deadline: Dec 18, 2019
Scholarship Deadline: Nov 20, 2019
Discounted Registration Deadline: Jan 23, 2020

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

Sponsored by Merck & Co., Inc.


Summary of Meeting:
Development of effective prophylactic human immunodeficiency virus (HIV) vaccines are still urgently needed to halt the spread of the HIV/AIDS pandemic. However, development of these vaccines has proven to be a challenge that, despite intensive research efforts over the last 30 years, science has failed to surmount. Nevertheless, the prospects for an effective HIV vaccine have recently been transformed by a series of advances in science. These advances suggest that induction of broadly-reactive antibodies that confer protection via neutralization and/or neutralization-independent mechanisms and elicitation of cytotoxic (CD8) T cell responses can potentially eradicate the virus early after transmission and may ultimately prove to be achievable goals for drug development. This conference will bring together interdisciplinary investigators whose complementary expertise will synergize to inform HIV vaccine design and evaluation to discuss progress and outstanding challenges in areas such as: 1) The design of immunogens and strategies for optimization of germinal center responses to elicit HIV-1 broadly neutralizing antibodies; 2) Identifying prospects for harnessing other antibody effector functions to confer protection; 3) Developing approaches for eliciting rapidly-acting, efficacious HIV-specific CD8 T cell responses; and 4) How to use novel technologies, animal model systems and small-scale clinical trials to inform vaccine development efforts. This conference is being held jointly with HIV Pathogenesis and Cure. This pairing will provide an opportunity for interaction between investigators working in these related areas, and for joint discussion of therapeutic vaccination strategies.

View Meeting Program

Scholarships/Awards


Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation


Ayushman Dobhal
All India Institute of Medical Sciences, India

Samuel Adetona Fayemiwo
University of Ibadan, Nigeria

Celestin Godwe
Center of Research for Emerging and Re-Emerging Diseases CREMER, Cameroon

Michael Muganga Kikonyogo
Uganda Virus Research Institute, Uganda

Christopher Kintu
Makerere University School of Medicine, Uganda

Nitesh Mishra
All India Institute of Medical Sciences, India

Babatunde Olanrewaju Motayo
Federal Medical Centre, Abeokuta, Nigeria

Enoch Sekayita Muyanja
Uganda Virus Research Institute-International AIDS Vaccine Initiative, Uganda

Ritah Faith Nakiboneka
Uganda Virus Research Institute, Uganda

Brenda Apio Okech
UVRI-IAVI HIV Vaccine Program, Uganda

Simone Irene Richardson
National Institute for Communicable Diseases, South Africa

Jyoti Sutar
National Institute for Research in Reproductive Health, India